Toronto - Delayed Quote CAD

Big Pharma Split Corp. (PRM-PA.TO)

Compare
10.05 +0.05 (+0.50%)
At close: December 20 at 12:59:19 PM EST
Loading Chart for PRM-PA.TO
DELL
  • Previous Close 10.00
  • Open 10.05
  • Bid 10.02 x --
  • Ask 10.22 x --
  • Day's Range 10.05 - 10.05
  • 52 Week Range 9.30 - 10.59
  • Volume 100
  • Avg. Volume 523
  • Market Cap (intraday) --
  • Beta (5Y Monthly) 0.88
  • PE Ratio (TTM) 3.08
  • EPS (TTM) 3.27
  • Earnings Date --
  • Forward Dividend & Yield 0.50 (5.09%)
  • Ex-Dividend Date Jun 28, 2024
  • 1y Target Est --

Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.

www.harvestportfolios.com/closed-end-funds/big-pharma-split-corp/

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: PRM-PA.TO

View More

Performance Overview: PRM-PA.TO

Trailing total returns as of 12/20/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

PRM-PA.TO
7.67%
S&P/TSX Composite index
17.37%

1-Year Return

PRM-PA.TO
8.18%
S&P/TSX Composite index
18.04%

3-Year Return

PRM-PA.TO
11.29%
S&P/TSX Composite index
18.61%

5-Year Return

PRM-PA.TO
21.41%
S&P/TSX Composite index
44.16%

Compare To: PRM-PA.TO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PRM-PA.TO

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -201.16%

  • Return on Assets (ttm)

    -0.69%

  • Return on Equity (ttm)

    -3.63%

  • Revenue (ttm)

    320.82k

  • Net Income Avi to Common (ttm)

    -645.35k

  • Diluted EPS (ttm)

    3.27

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    204.19k

  • Total Debt/Equity (mrq)

    64.96%

  • Levered Free Cash Flow (ttm)

    4.09M

Research Analysis: PRM-PA.TO

View More

Company Insights: PRM-PA.TO

Research Reports: PRM-PA.TO

View More

People Also Watch

Waiting for permission
Allow microphone access to enable voice search

Try again.